Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill

This article was originally published in The Tan Sheet

Executive Summary

Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.
Advertisement

Related Content

People In Brief
People In Brief
FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit
CFSAN Post May Remain Unfilled Pending Food Safety Legislation Passage
FDA Chief Counsel Ralph Tyler Begins Tenure With A Focus On "The Jungle"
FDA Chief Counsel Has History With Sharfstein
FDA Chief Counsel Has History With Sharfstein

Topics

Advertisement
UsernamePublicRestriction

Register

PS105173

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel